nodes	percent_of_prediction	percent_of_DWPC	metapath
Salsalate—PTGS2—glaucoma	0.836	1	CbGaD
Salsalate—Bronchospasm—Carteolol—glaucoma	0.00353	0.0254	CcSEcCtD
Salsalate—Bronchospasm—Levobunolol—glaucoma	0.00334	0.024	CcSEcCtD
Salsalate—Nausea—Physostigmine—glaucoma	0.00274	0.0197	CcSEcCtD
Salsalate—Tinnitus—Diclofenamide—glaucoma	0.00264	0.0189	CcSEcCtD
Salsalate—Deafness—Pilocarpine—glaucoma	0.00252	0.0181	CcSEcCtD
Salsalate—Tinnitus—Methazolamide—glaucoma	0.00243	0.0174	CcSEcCtD
Salsalate—Vertigo—Methazolamide—glaucoma	0.00204	0.0146	CcSEcCtD
Salsalate—Bronchospasm—Dorzolamide—glaucoma	0.00203	0.0146	CcSEcCtD
Salsalate—Haemorrhage—Apraclonidine—glaucoma	0.00201	0.0145	CcSEcCtD
Salsalate—Bronchospasm—Pilocarpine—glaucoma	0.00192	0.0138	CcSEcCtD
Salsalate—Hypotension—Carteolol—glaucoma	0.00191	0.0137	CcSEcCtD
Salsalate—Anaphylactic shock—Methazolamide—glaucoma	0.00185	0.0133	CcSEcCtD
Salsalate—Hypotension—Carbachol—glaucoma	0.00183	0.0132	CcSEcCtD
Salsalate—Hypotension—Levobunolol—glaucoma	0.0018	0.013	CcSEcCtD
Salsalate—Deafness—Betaxolol—glaucoma	0.00175	0.0126	CcSEcCtD
Salsalate—Tinnitus—Acetazolamide—glaucoma	0.00168	0.0121	CcSEcCtD
Salsalate—Acetylsalicylic acid—TP53—glaucoma	0.00163	0.174	CrCbGaD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00158	0.1	CbGpPWpGaD
Salsalate—Hepatitis—Pilocarpine—glaucoma	0.00156	0.0112	CcSEcCtD
Salsalate—Abdominal pain—Carbachol—glaucoma	0.00155	0.0111	CcSEcCtD
Salsalate—Tinnitus—Dorzolamide—glaucoma	0.00154	0.0111	CcSEcCtD
Salsalate—Urticaria—Levobunolol—glaucoma	0.00153	0.011	CcSEcCtD
Salsalate—Tinnitus—Travoprost—glaucoma	0.00153	0.011	CcSEcCtD
Salsalate—Vertigo—Bimatoprost—glaucoma	0.00153	0.011	CcSEcCtD
Salsalate—Tinnitus—Brinzolamide—glaucoma	0.00151	0.0109	CcSEcCtD
Salsalate—Urticaria—Methazolamide—glaucoma	0.00147	0.0105	CcSEcCtD
Salsalate—Tinnitus—Pilocarpine—glaucoma	0.00146	0.0104	CcSEcCtD
Salsalate—Rash—Metipranolol—glaucoma	0.00139	0.00998	CcSEcCtD
Salsalate—Dermatitis—Metipranolol—glaucoma	0.00139	0.00997	CcSEcCtD
Salsalate—Diarrhoea—Carbachol—glaucoma	0.00134	0.00963	CcSEcCtD
Salsalate—Bronchospasm—Betaxolol—glaucoma	0.00133	0.00957	CcSEcCtD
Salsalate—Diarrhoea—Levobunolol—glaucoma	0.00132	0.00948	CcSEcCtD
Salsalate—Angioedema—Dorzolamide—glaucoma	0.00131	0.00943	CcSEcCtD
Salsalate—Nausea—Metipranolol—glaucoma	0.00131	0.0094	CcSEcCtD
Salsalate—Vertigo—Dorzolamide—glaucoma	0.00129	0.00927	CcSEcCtD
Salsalate—Vertigo—Travoprost—glaucoma	0.00129	0.00923	CcSEcCtD
Salsalate—Anaphylactic shock—Acetazolamide—glaucoma	0.00128	0.00919	CcSEcCtD
Salsalate—Vertigo—Brinzolamide—glaucoma	0.00127	0.00912	CcSEcCtD
Salsalate—Rash—Diclofenamide—glaucoma	0.00127	0.00909	CcSEcCtD
Salsalate—Diarrhoea—Methazolamide—glaucoma	0.00127	0.00909	CcSEcCtD
Salsalate—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00126	0.0797	CbGpPWpGaD
Salsalate—Hepatitis—Clonidine—glaucoma	0.00125	0.00895	CcSEcCtD
Salsalate—Rash—Carbachol—glaucoma	0.00124	0.00887	CcSEcCtD
Salsalate—Dermatitis—Carbachol—glaucoma	0.00124	0.00887	CcSEcCtD
Salsalate—Nausea—Carteolol—glaucoma	0.00121	0.00871	CcSEcCtD
Salsalate—Trisalicylate-choline—PTGS2—glaucoma	0.00121	0.129	CrCbGaD
Salsalate—Nausea—Diclofenamide—glaucoma	0.00119	0.00857	CcSEcCtD
Salsalate—Anaphylactic shock—Dorzolamide—glaucoma	0.00117	0.00842	CcSEcCtD
Salsalate—Gastrointestinal pain—Apraclonidine—glaucoma	0.00117	0.0084	CcSEcCtD
Salsalate—Rash—Methazolamide—glaucoma	0.00117	0.00837	CcSEcCtD
Salsalate—Dermatitis—Methazolamide—glaucoma	0.00117	0.00836	CcSEcCtD
Salsalate—Nausea—Carbachol—glaucoma	0.00116	0.00836	CcSEcCtD
Salsalate—Tinnitus—Clonidine—glaucoma	0.00116	0.00834	CcSEcCtD
Salsalate—Hypotension—Brimonidine—glaucoma	0.00115	0.00824	CcSEcCtD
Salsalate—Nausea—Levobunolol—glaucoma	0.00115	0.00823	CcSEcCtD
Salsalate—Abdominal pain—Apraclonidine—glaucoma	0.00113	0.00812	CcSEcCtD
Salsalate—Rash—Latanoprost—glaucoma	0.00113	0.0081	CcSEcCtD
Salsalate—Dermatitis—Latanoprost—glaucoma	0.00113	0.0081	CcSEcCtD
Salsalate—Nausea—Methazolamide—glaucoma	0.0011	0.00789	CcSEcCtD
Salsalate—Hypotension—Dorzolamide—glaucoma	0.0011	0.00787	CcSEcCtD
Salsalate—Hypotension—Travoprost—glaucoma	0.00109	0.00784	CcSEcCtD
Salsalate—Bronchospasm—Timolol—glaucoma	0.00109	0.00782	CcSEcCtD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00108	0.0685	CbGpPWpGaD
Salsalate—Hypotension—Brinzolamide—glaucoma	0.00108	0.00774	CcSEcCtD
Salsalate—Hypotension—Pilocarpine—glaucoma	0.00104	0.00744	CcSEcCtD
Salsalate—Urticaria—Acetazolamide—glaucoma	0.00102	0.0073	CcSEcCtD
Salsalate—Tinnitus—Betaxolol—glaucoma	0.00101	0.00726	CcSEcCtD
Salsalate—Angioedema—Clonidine—glaucoma	0.000992	0.00712	CcSEcCtD
Salsalate—Diarrhoea—Apraclonidine—glaucoma	0.000979	0.00703	CcSEcCtD
Salsalate—Gastrointestinal pain—Dorzolamide—glaucoma	0.00096	0.00689	CcSEcCtD
Salsalate—Gastrointestinal pain—Travoprost—glaucoma	0.000956	0.00686	CcSEcCtD
Salsalate—Urticaria—Dorzolamide—glaucoma	0.000932	0.00669	CcSEcCtD
Salsalate—Abdominal pain—Dorzolamide—glaucoma	0.000928	0.00666	CcSEcCtD
Salsalate—Abdominal pain—Travoprost—glaucoma	0.000924	0.00663	CcSEcCtD
Salsalate—Urticaria—Brinzolamide—glaucoma	0.000917	0.00658	CcSEcCtD
Salsalate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000907	0.00651	CcSEcCtD
Salsalate—Dermatitis—Apraclonidine—glaucoma	0.000902	0.00647	CcSEcCtD
Salsalate—Abdominal pain—Pilocarpine—glaucoma	0.000877	0.00629	CcSEcCtD
Salsalate—Diarrhoea—Acetazolamide—glaucoma	0.000876	0.00629	CcSEcCtD
Salsalate—Rash—Bimatoprost—glaucoma	0.000875	0.00628	CcSEcCtD
Salsalate—Dermatitis—Bimatoprost—glaucoma	0.000874	0.00628	CcSEcCtD
Salsalate—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000858	0.0544	CbGpPWpGaD
Salsalate—Nausea—Apraclonidine—glaucoma	0.00085	0.0061	CcSEcCtD
Salsalate—Vertigo—Betaxolol—glaucoma	0.000849	0.00609	CcSEcCtD
Salsalate—Hypotension—Clonidine—glaucoma	0.000828	0.00594	CcSEcCtD
Salsalate—Tinnitus—Timolol—glaucoma	0.000827	0.00593	CcSEcCtD
Salsalate—Nausea—Bimatoprost—glaucoma	0.000824	0.00592	CcSEcCtD
Salsalate—Diarrhoea—Dorzolamide—glaucoma	0.000803	0.00576	CcSEcCtD
Salsalate—Diarrhoea—Travoprost—glaucoma	0.0008	0.00574	CcSEcCtD
Salsalate—Diarrhoea—Brinzolamide—glaucoma	0.00079	0.00567	CcSEcCtD
Salsalate—Rash—Brimonidine—glaucoma	0.000775	0.00556	CcSEcCtD
Salsalate—Dermatitis—Brimonidine—glaucoma	0.000774	0.00556	CcSEcCtD
Salsalate—Nausea—Acetazolamide—glaucoma	0.000761	0.00546	CcSEcCtD
Salsalate—Diarrhoea—Pilocarpine—glaucoma	0.000759	0.00545	CcSEcCtD
Salsalate—Rash—Dorzolamide—glaucoma	0.00074	0.00531	CcSEcCtD
Salsalate—Dermatitis—Dorzolamide—glaucoma	0.000739	0.00531	CcSEcCtD
Salsalate—Rash—Travoprost—glaucoma	0.000737	0.00529	CcSEcCtD
Salsalate—Dermatitis—Travoprost—glaucoma	0.000736	0.00528	CcSEcCtD
Salsalate—Salicylate-sodium—PTGS2—glaucoma	0.00073	0.0781	CrCbGaD
Salsalate—Nausea—Brimonidine—glaucoma	0.00073	0.00524	CcSEcCtD
Salsalate—Rash—Brinzolamide—glaucoma	0.000728	0.00522	CcSEcCtD
Salsalate—Dermatitis—Brinzolamide—glaucoma	0.000727	0.00522	CcSEcCtD
Salsalate—Gastrointestinal pain—Clonidine—glaucoma	0.000724	0.0052	CcSEcCtD
Salsalate—Hypotension—Betaxolol—glaucoma	0.000721	0.00517	CcSEcCtD
Salsalate—Angioedema—Timolol—glaucoma	0.000705	0.00506	CcSEcCtD
Salsalate—Urticaria—Clonidine—glaucoma	0.000704	0.00505	CcSEcCtD
Salsalate—Abdominal pain—Clonidine—glaucoma	0.0007	0.00503	CcSEcCtD
Salsalate—Rash—Pilocarpine—glaucoma	0.000699	0.00502	CcSEcCtD
Salsalate—Dermatitis—Pilocarpine—glaucoma	0.000699	0.00501	CcSEcCtD
Salsalate—Nausea—Dorzolamide—glaucoma	0.000697	0.005	CcSEcCtD
Salsalate—Nausea—Travoprost—glaucoma	0.000694	0.00498	CcSEcCtD
Salsalate—Vertigo—Timolol—glaucoma	0.000693	0.00498	CcSEcCtD
Salsalate—Nausea—Brinzolamide—glaucoma	0.000685	0.00492	CcSEcCtD
Salsalate—Ketorolac—PTGS2—glaucoma	0.00066	0.0707	CrCbGaD
Salsalate—Nausea—Pilocarpine—glaucoma	0.000659	0.00473	CcSEcCtD
Salsalate—Anaphylactic shock—Timolol—glaucoma	0.00063	0.00452	CcSEcCtD
Salsalate—Urticaria—Betaxolol—glaucoma	0.000613	0.0044	CcSEcCtD
Salsalate—Diarrhoea—Clonidine—glaucoma	0.000606	0.00435	CcSEcCtD
Salsalate—Hypotension—Timolol—glaucoma	0.000589	0.00423	CcSEcCtD
Salsalate—Rash—Clonidine—glaucoma	0.000558	0.00401	CcSEcCtD
Salsalate—Dermatitis—Clonidine—glaucoma	0.000558	0.004	CcSEcCtD
Salsalate—Tiaprofenic acid—PTGS2—glaucoma	0.000538	0.0576	CrCbGaD
Salsalate—Diarrhoea—Betaxolol—glaucoma	0.000528	0.00379	CcSEcCtD
Salsalate—Nausea—Clonidine—glaucoma	0.000526	0.00378	CcSEcCtD
Salsalate—Gastrointestinal pain—Timolol—glaucoma	0.000515	0.0037	CcSEcCtD
Salsalate—Nepafenac—PTGS2—glaucoma	0.000512	0.0548	CrCbGaD
Salsalate—Magnesium salicylate—PTGS2—glaucoma	0.000501	0.0535	CrCbGaD
Salsalate—Olsalazine—PTGS2—glaucoma	0.000501	0.0535	CrCbGaD
Salsalate—Urticaria—Timolol—glaucoma	0.0005	0.00359	CcSEcCtD
Salsalate—Abdominal pain—Timolol—glaucoma	0.000498	0.00357	CcSEcCtD
Salsalate—Fenbufen—PTGS2—glaucoma	0.00049	0.0524	CrCbGaD
Salsalate—Rash—Betaxolol—glaucoma	0.000486	0.00349	CcSEcCtD
Salsalate—Dermatitis—Betaxolol—glaucoma	0.000486	0.00349	CcSEcCtD
Salsalate—Diflunisal—PTGS2—glaucoma	0.000471	0.0503	CrCbGaD
Salsalate—Nausea—Betaxolol—glaucoma	0.000458	0.00329	CcSEcCtD
Salsalate—Diarrhoea—Timolol—glaucoma	0.000431	0.00309	CcSEcCtD
Salsalate—Meclofenamic acid—PTGS2—glaucoma	0.000419	0.0449	CrCbGaD
Salsalate—Rash—Timolol—glaucoma	0.000397	0.00285	CcSEcCtD
Salsalate—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.000397	0.0252	CbGpPWpGaD
Salsalate—Dermatitis—Timolol—glaucoma	0.000397	0.00285	CcSEcCtD
Salsalate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000396	0.0251	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000389	0.0247	CbGpPWpGaD
Salsalate—Nausea—Timolol—glaucoma	0.000374	0.00269	CcSEcCtD
Salsalate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000368	0.0234	CbGpPWpGaD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000359	0.0228	CbGpPWpGaD
Salsalate—Fenoprofen—PTGS2—glaucoma	0.000352	0.0376	CrCbGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000351	0.0222	CbGpPWpGaD
Salsalate—Mefenamic acid—PTGS2—glaucoma	0.000326	0.0349	CrCbGaD
Salsalate—Acetylsalicylic acid—PTGS2—glaucoma	0.000318	0.034	CrCbGaD
Salsalate—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000315	0.02	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000304	0.0193	CbGpPWpGaD
Salsalate—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000295	0.0187	CbGpPWpGaD
Salsalate—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000288	0.0183	CbGpPWpGaD
Salsalate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000285	0.0181	CbGpPWpGaD
Salsalate—Salicylic acid—PTGS2—glaucoma	0.000262	0.028	CrCbGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00025	0.0159	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000241	0.0153	CbGpPWpGaD
Salsalate—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000239	0.0152	CbGpPWpGaD
Salsalate—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000234	0.0149	CbGpPWpGaD
Salsalate—Flurbiprofen—PTGS2—glaucoma	0.000229	0.0245	CrCbGaD
Salsalate—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000214	0.0136	CbGpPWpGaD
Salsalate—Ketoprofen—PTGS2—glaucoma	0.000208	0.0222	CrCbGaD
Salsalate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000207	0.0131	CbGpPWpGaD
Salsalate—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000207	0.0131	CbGpPWpGaD
Salsalate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.0002	0.0127	CbGpPWpGaD
Salsalate—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000195	0.0124	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000188	0.0119	CbGpPWpGaD
Salsalate—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.00018	0.0114	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000167	0.0106	CbGpPWpGaD
Salsalate—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000155	0.00981	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000149	0.00946	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000138	0.00875	CbGpPWpGaD
Salsalate—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000133	0.00844	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000133	0.00843	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000133	0.00842	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.000124	0.00785	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—NGFR—glaucoma	0.000113	0.0072	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.00011	0.00697	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000107	0.00678	CbGpPWpGaD
Salsalate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000106	0.00674	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	0.000105	0.00668	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000103	0.00651	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—BDNF—glaucoma	9.87e-05	0.00626	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	9.84e-05	0.00624	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—NARFL—glaucoma	9.66e-05	0.00613	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CA5A—glaucoma	9.66e-05	0.00613	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—IL1A—glaucoma	9.48e-05	0.00601	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	8.89e-05	0.00564	CbGpPWpGaD
Salsalate—PTGS1—Biological oxidations—GSTM1—glaucoma	8.78e-05	0.00557	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	8.46e-05	0.00537	CbGpPWpGaD
Salsalate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	8.36e-05	0.0053	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.15e-05	0.00517	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—NARFL—glaucoma	7.67e-05	0.00487	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CA5A—glaucoma	7.67e-05	0.00487	CbGpPWpGaD
Salsalate—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	7.62e-05	0.00483	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	7.46e-05	0.00473	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	7.34e-05	0.00465	CbGpPWpGaD
Salsalate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	7.13e-05	0.00452	CbGpPWpGaD
Salsalate—PTGS2—Disease—LRP12—glaucoma	6.94e-05	0.0044	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	6.76e-05	0.00429	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	6.72e-05	0.00426	CbGpPWpGaD
Salsalate—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	6.6e-05	0.00419	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	5.75e-05	0.00365	CbGpPWpGaD
Salsalate—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	5.71e-05	0.00362	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	5.03e-05	0.00319	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	4.92e-05	0.00312	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CA1—glaucoma	4.72e-05	0.00299	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—MMP9—glaucoma	4.66e-05	0.00296	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CTSA—glaucoma	4.57e-05	0.0029	CbGpPWpGaD
Salsalate—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	4.54e-05	0.00288	CbGpPWpGaD
Salsalate—PTGS2—Disease—FGFR1OP—glaucoma	4.47e-05	0.00284	CbGpPWpGaD
Salsalate—PTGS2—Disease—HEYL—glaucoma	4.47e-05	0.00284	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CA2—glaucoma	4.32e-05	0.00274	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.22e-05	0.00268	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.22e-05	0.00268	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CA1—glaucoma	3.75e-05	0.00238	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CTSA—glaucoma	3.63e-05	0.0023	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TNF—glaucoma	3.59e-05	0.00228	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CA2—glaucoma	3.43e-05	0.00217	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	3.42e-05	0.00217	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.35e-05	0.00212	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.35e-05	0.00212	CbGpPWpGaD
Salsalate—PTGS2—Spinal Cord Injury—TP53—glaucoma	3.16e-05	0.00201	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—TXN—glaucoma	3.04e-05	0.00193	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.85e-05	0.00181	CbGpPWpGaD
Salsalate—PTGS2—Disease—HDAC9—glaucoma	2.79e-05	0.00177	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.77e-05	0.00176	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.75e-05	0.00174	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	2.44e-05	0.00155	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—TXN—glaucoma	2.41e-05	0.00153	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GSTT1—glaucoma	2.36e-05	0.0015	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.2e-05	0.0014	CbGpPWpGaD
Salsalate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.18e-05	0.00138	CbGpPWpGaD
Salsalate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.15e-05	0.00136	CbGpPWpGaD
Salsalate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.9e-05	0.00121	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—ABCA1—glaucoma	1.88e-05	0.00119	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CYP1B1—glaucoma	1.88e-05	0.00119	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GSTT1—glaucoma	1.87e-05	0.00119	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—GSTM1—glaucoma	1.5e-05	0.000953	CbGpPWpGaD
Salsalate—PTGS2—Disease—CDKN2B—glaucoma	1.5e-05	0.000952	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—ABCA1—glaucoma	1.49e-05	0.000946	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CYP1B1—glaucoma	1.49e-05	0.000946	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—MTHFR—glaucoma	1.33e-05	0.000842	CbGpPWpGaD
Salsalate—PTGS2—Disease—MTHFR—glaucoma	1.26e-05	0.000798	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—APOE—glaucoma	1.24e-05	0.000784	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—CAV1—glaucoma	1.22e-05	0.000777	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—GSTM1—glaucoma	1.19e-05	0.000756	CbGpPWpGaD
Salsalate—PTGS2—Disease—APOE—glaucoma	1.17e-05	0.000743	CbGpPWpGaD
Salsalate—PTGS2—Disease—CAV1—glaucoma	1.16e-05	0.000736	CbGpPWpGaD
Salsalate—PTGS2—Disease—BAD—glaucoma	1.09e-05	0.000692	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—MTHFR—glaucoma	1.05e-05	0.000668	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—APOE—glaucoma	9.81e-06	0.000622	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—CAV1—glaucoma	9.72e-06	0.000617	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—NOS3—glaucoma	9.26e-06	0.000587	CbGpPWpGaD
Salsalate—PTGS2—Disease—NOS3—glaucoma	8.78e-06	0.000557	CbGpPWpGaD
Salsalate—PTGS1—Metabolism—PTGS2—glaucoma	8.47e-06	0.000537	CbGpPWpGaD
Salsalate—PTGS2—Disease—CDKN1B—glaucoma	7.6e-06	0.000482	CbGpPWpGaD
Salsalate—PTGS2—Metabolism—NOS3—glaucoma	7.35e-06	0.000466	CbGpPWpGaD
